Given the current high incidence of cerebral circulatory disorders and the challenging treatment of such patients, developing therapies and medications for these conditions is urgent. The proportion of patients undergoing various reperfusion techniques is increasing, and so is the medical community's need for novel agents with high efficacy and low complication rate.